Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

McKesson Corporation (MCK - Analyst Report) recently announced that it has completed its previously announced acquisition of PSS World Medical, Inc.

McKesson paid $2.1 billion for the acquisition including PSS World Medical's debt of about $480 million and related transaction costs.  The acquisition was announced on Oct 25, 2012.

In Dec 2012, McKesson received a notification of early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, in relation with its proposed acquisition of erstwhile PSS World Medical Inc.

At the time of announcing the acquisition, McKesson had said that it expects to generate more than $100 million in annual savings (pre-tax) by the fourth year after the closure of the deal. The deal acquisition is expected to add 15 to 25 cents per share to the company's bottom line after a year of closing.

McKesson recently lowered its earnings guidance range for fiscal 2013. The company now expects earnings (excluding special items) in the range of $7.10–$7.30 per share (previous projection: $7.15–$7.35 share).

The erstwhile PSS World Medical will be combined with McKesson’s Medical Surgical Distribution business. The addition of PSS World Medical to the company’s product line will bolster the Medical Surgical Distribution business of McKesson.

We note that McKesson has been quite active on the acquisition front recently. In Nov 2012, the company inked a deal with Emendo Ltd. to acquire the latter.

McKesson currently carries a Zacks Rank #3 (Hold). Nevertheless, stocks like AmerisourceBergen (ABC - Analyst Report), Cardinal Health (CAH - Analyst Report) and CVS Caremark Corporation (CVS - Analyst Report) which operate in the same sector as McKesson, currently look attractive with a Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BOFL HOLDING BOFI 85.58 +5.32%
DIXIE GROUP DXYN 15.41 +4.98%
CELL THERAPE CTIC 3.13 +4.68%
RAMBUS INC RMBS 12.23 +3.73%
DAIMLER AG DDAIF 93.03 +2.95%